MRI scans could spare breast cancer patients from toxic chemotherapy
NCT ID NCT07327021
Summary
This study tests whether MRI scans can identify patients with aggressive triple-negative breast cancer who can safely skip the harshest part of chemotherapy. All participants receive initial treatment with four drugs. Those whose MRI shows no remaining cancer after this phase skip the toxic anthracycline chemotherapy and go straight to surgery. The goal is to maintain cancer control while reducing treatment side effects and improving quality of life.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TNBC, TRIPLE NEGATIVE BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Sheba Medical Center
RECRUITINGTel Litwinsky, Israel
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Tel Aviv Sourasky Medical Center
RECRUITINGTel Aviv, Israel
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.